Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Will Supplement Reduced Sales Force With Part-Time Reps

This article was originally published in The Pink Sheet Daily

Executive Summary

Wyeth will cut full-times sales force by 25%-30% but will add part-time reps, resulting in a net reduction of approximately 15%, the company says.

You may also be interested in...



Forest Credits Lexapro Growth To Less Detailing By Competitors

The antidepressant market has “normalized” following suicidality concerns, COO Goodman says.

Forest Credits Lexapro Growth To Less Detailing By Competitors

The antidepressant market has “normalized” following suicidality concerns, COO Goodman says.

Wyeth Begins Recruitment Of Part-Time Sales Reps

Wyeth will begin to implement its plan to integrate part-time employees into its U.S. primary care sales force starting in late November

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062876

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel